193 related articles for article (PubMed ID: 2669278)
1. Lipid abnormalities in renal transplant recipients treated with cyclosporine.
Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278
[No Abstract] [Full Text] [Related]
2. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
[No Abstract] [Full Text] [Related]
3. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
Kupin W; Venkat KK; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
[No Abstract] [Full Text] [Related]
4. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
[No Abstract] [Full Text] [Related]
5. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
[No Abstract] [Full Text] [Related]
6. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
[No Abstract] [Full Text] [Related]
7. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
[No Abstract] [Full Text] [Related]
8. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
[No Abstract] [Full Text] [Related]
9. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
11. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
12. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
[No Abstract] [Full Text] [Related]
13. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
[No Abstract] [Full Text] [Related]
14. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
Rosenblum ND; Harmon WE; Levey RH
Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052
[No Abstract] [Full Text] [Related]
15. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
[No Abstract] [Full Text] [Related]
16. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
[No Abstract] [Full Text] [Related]
17. Prospective evaluation of changes in lipid profiles in cyclosporine-treated renal transplant patients.
Markell MS; Brown CD; Butt KM; Friedman EA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1497-9. PubMed ID: 2652482
[No Abstract] [Full Text] [Related]
18. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
[No Abstract] [Full Text] [Related]
19. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
[No Abstract] [Full Text] [Related]
20. Current results with triple therapy for heart transplantation.
Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
